Pargyline

Pargyline

SCHEMBL2657939

C#CCN.C#CCN(C)Cc1ccccc1

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MAOAMAOB

The experimentally established mechanism targets of Pargyline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ MAOB known ✓ P27338 2/20 0.86
▸ MAOA known ✓ P21397 1/20 0.86
▸ PYCR1 P32322 17/20 0.86
▸ LMNA P02545 2/20 0.86
▸ USP2 O75604 1/20 0.86
▸ CYP3A4 P08684 1/20 0.86
▸ TSHR P16473 1/20 0.86
▸ ALDH1A1 P00352 1/20 0.83
▸ BLM P54132 1/20 0.83
▸ SMN1; SMN2 Q16637 1/20 0.83
▸ CARM1 Q86X55 1/20 0.55
▸ PRMT6 Q96LA8 1/20 0.55
▸ PRMT8 Q9NR22 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pargyline SCHEMBL18036659 0.93 PYCR1 (1.00) PYCR1LMNAMAOBUSP2CYP3A4
Pargyline SCHEMBL2045 0.93 PYCR1 (1.00) PYCR1LMNAMAOBUSP2CYP3A4
Pargyline SCHEMBL121111 0.91 LMNA (1.00) PYCR1LMNAMAOBUSP2CYP3A4
Pargyline SCHEMBL7363311 0.91 PYCR1 (0.96) PYCR1LMNAMAOBUSP2CYP3A4
Pargyline SCHEMBL5981667 0.87 PYCR1 (0.75) PYCR1LMNAMAOBUSP2CYP3A4
Pargyline SCHEMBL4441967 0.80 PYCR1 (0.75) PYCR1LMNAMAOBUSP2CYP3A4
SCHEMBL11896612 0.78 PYCR1 (0.72) PYCR1LMNAMAOBUSP2CYP3A4
SCHEMBL5680713 0.78 PYCR1 (0.70) PYCR1LMNAMAOBUSP2CYP3A4
SCHEMBL10033796 0.78 PYCR1 (0.71) PYCR1LMNAMAOBUSP2CYP3A4
Pargyline SCHEMBL1240794 0.78 PYCR1 (0.65) PYCR1LMNAMAOBUSP2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994848-A1 GLUCAGON ANTAGONISTS/INVERSE AGONISTS NOVO NORDISK A/S (DK) 2000-04-26 — — EP disclosed
WO-1999001423-A1 GLUCAGON ANTAGONISTS/INVERSE AGONISTS NOVO NORDISK A/S (DK) 1999-01-14 — — WO disclosed
Send feedback